Verus Investment Partners, a leading private equity investment firm, announced today that it has sold its portfolio company VanDeMark Chemical Inc., Lockport, NY.
There was no disclosure of financial terms.
VanDeMark, an independent manufacturer of phosgene and phosgene derivatives, offers a range of more than 30 chemical compounds used in the production of pharmaceuticals, agrochemicals, plastics and polymers, and CASE (coatings, adhesives, sealants, elastomers) end markets.
Christopher P. Fuller, Managing Partner of Verus, VanDeMark’s largest and lead private equity owner said, “Since we acquired VanDeMark in 2012 it has increased its revenue, entered new markets and extended the range of applications for its portfolio of chemical compounds based on phosgenation chemistry. The company also successfully grew by acquisition with its transformative purchase of Framochem Kft in Hungary in 2014. We now wish VanDeMark continued success.”
Under the terms of the agreement, VanDeMark’s Chief Executive Officer Mike Kucharski, who joined the company in 1983, will continue as CEO, as will the rest of the management team.
“Verus has been an incredibly supportive partner, helping me and my team take VanDeMark to the next level though investments in capital, people and processes to improve the business,” said Kucharski. “The acquisition of Framochem, which Verus sourced and led, opened up international markets and transformed the company from the largest independent phosgene producer in North America to the leading global player that we are today.”
William Blair and Houlihan Lokey served as financial advisors to VanDeMark, and Arnold & Porter was counsel to the selling shareholders.
About VanDeMark: VanDeMark is the largest independent manufacturer of specialty phosgene derivatives VanDeMark products are primarily used in pharmaceuticals, agrochemicals, plastics/polymers, and CASE (coatings, adhesives, sealants, elastomers) applications. The Company was founded in 1951 and is headquartered in Lockport, New York.
About Verus Partners: Verus Investment Partners, formerly Uni-World Capital, is a New York-based private equity firm focused on making leveraged buyout and growth equity investments in lower-middle market companies. The firm seeks to partner with management teams where it can leverage the Verus Private Equity team’s collective business experience, corporate relationships and strategic and financial expertise in order to help enhance a company’s strategic positioning and drive profitable growth.
Source: Verus Investment Partners
